Indian pharma stocks fell 2.6% after U.S. President Trump announced a 100% tariff on branded and patented drugs, effective October 1. Analysts say the immediate impact may be limited, but concerns remain over future tariffs on complex generics. Read also Post navigation Pakistan test squad for South Africa series Pakistan–India Asia Cup Final to Begin with Separate Toss Interviews
